Baxter International's EBIT per Share for the
three
months ended in Dec. 2024 was $-0.82.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.36.
During the past 12 months, the average EBIT per Share Growth Rate of Baxter International was -38.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -31.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Baxter International's EBIT per Share or its related term are showing as below:
BAX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -45.2 Med: 6.8 Max: 52.5
Current: -31.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Baxter International was 52.50% per year. The lowest was -45.20% per year. And the median was 6.80% per year.
BAX's 3-Year EBIT Growth Rate is ranked worse than 85.3% of 721
companies
in the Medical Devices & Instruments industry
Industry Median: 5.6
vs BAX: -31.20
Baxter International EBIT per Share Historical Data
The historical data trend for Baxter International's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.36
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (NYSE:BAX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Baxter International EBIT per Share Related Terms
Thank you for viewing the detailed overview of Baxter International's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BAX has been successfully added to your 